Thursday, October 24, 2024 3:58:42 PM
They aren't selling to fund anything. The dilution is from old convertible notes that matured last May. John used toxic financing to buy the shell from Synergy Management. All of the convertible debt was incurred and planned before Ronn Ford latched himself to this turd. It's in the filings, go read them. John had the shell a year before finding a sucker. It had ZERO notes when it was bought from Synergy as LPHM. The O/S was under 10M shares. It's now almost 2B.
Recent AIMN News
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
